An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)
Phase 3
Completed
- Conditions
- Insomnia
- Registration Number
- NCT00103818
- Lead Sponsor
- H. Lundbeck A/S
- Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of MK0928 for insomnia (a sleep disorder).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
- Adult outpatients who are between the ages of 18 and 64
Exclusion Criteria
- Adults who do not have a diagnosis of insomnia (a sleep disorder)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Patient-reported amount of sleep and time to fall asleep at night after 3 months After 3 months
- Secondary Outcome Measures
Name Time Method Sleep quality After 3 months Patient-reported awakenings at night After 3 months Functioning after 3 months After 3 months